To accelerate the development of vaccines and immunotherapies against major global infectious diseases and cancers by decoding the human immune system.
Vaccines have helped us conquer and control a wide range of diseases, but we are increasingly held back by the limits of our scientific knowledge.
Today the diseases we battle are much more insidious and biologically complex than those we conquered in the past. Despite decades of work and billions in investment, vaccines for HIV, tuberculosis and cancers have evaded our best efforts and we remain unprepared against the next pandemic.
A new approach is needed, one that is rooted in identifying and understanding the common elements of the human immune system that span across global populations, and allows us to harness this knowledge and the collective intelligence of scientists worldwide towards prevention and control of infectious diseases and cancer.
Rapid innovations in genomics, bioinformatics and artificial intelligence are revolutionizing biomedical research and making reality advances not thought possible even five years ago.
Through our innovative business model and global consortium, the Human Vaccines Project is putting these technologies in the hands of the world’s top scientists by bringing together some of the world’s leading universities, companies and nonprofits under a coordinated effort to decode the human immune system and transform how we prevent and treat disease.